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To define the role of the auto-inhibitory egion of protein kinase C {PKC), Ar~"-'-L_~-Gly"~-Ala'-S.Leu26-Arg -'~, site-directed mutations were 
introduced into the basic residues. Three mutants, PKC man.;~, PKC Al'~zT, and PKC alu'-L-'3'''~, apparently fell into two distinct ypes with regard to 
their biochemical properties and biological activities, as judged by the enhancement of a c.fos promoter in Jurkat cells and by the initiation of 
germinal vesicle breakdown (GVBD) in Xenopus laevis ooeytes. {i) PKC a)":','3 and PKC ^ )"'7 had activators independent in vitro kinase activity, 
high pho~phorylation levels in vivo, and localized in both cytosolic and particulate fractions. These mutants were not fully biologically active. (ii) 
PKC ala~-2'2~'27 had a low phosphor),lation level in vivo, was found predominantly in the particulate fraction and was the most biologically active. 
Thes~ r~sults uggest that basic residues in the auto-inhibitory domain account for the regulation of kinase activity and the eytosolic retention of 
PKC. The particulate association or the cytosolie clearance of PKC may facilitate signal transduetion i  the cell. 
Protein kinase C; Auto-inhibitory egion; Mutation 
1. INTRODUCTION 
Protein kinase C (PKC) is a key enzyme involved in 
the regulation of various cellular responses, uch as cell 
growth, development, tumor promotion, secretion and 
gene regulation (see [1] for a review). The molecular 
mechanism by which PKC activity is regulated in the 
cell is an important issue due to its broad biological 
effects. Earlier studies on PKC have shown that limited 
proteolysis of this enzyme generates a fragment which 
carries the phorbol ester binding activity and a fragment 
that is catalytically active [2,31, indicating that PKC is 
composed of regulatory and catalytic domains. Cloning 
of various PKC cDNAs has revealed that putative ki- 
nase and regulatory domains can be found in all mem- 
bers of the PKC family (see [4] for a review). Consistant 
with this notion, it has been shown that phorbol ester 
binds to the N-terminal regulatory domain [5], and the 
catalytic domain has been shown to be sufficient to 
induce PKC-mediated cellular responses without phor- 
bol ester [61. 
A general mechanism for the regulation of protein 
kinase activity by an auto-inhibitory domain has been 
proposed for various protein kinases (see [7] for a re- 
view), including myosin light chain kinase [8,9], cal- 
ciurrdcalmodulin-dependent pro ein kinase 1I [10-12], 
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cAMP-dependent protein kinase [13], and PKC [14]. In 
the ease of PKC, the existence of such a built-in inhibi- 
tor was first suggested when a synthei, ie peptide con- 
taining the substrate-like motif, ArgZLL~ls2LGly 24- 
AIa2~-Leu-'6-A~ 27,was found to be a potent competitive 
inhibitor [14]. The proposed scheme is that the interac- 
tion of activator of PKC with the regulatory domain 
induces a conformational change that relieves the 
pseudo-substrate inhibition and elicits catalytic activity. 
Mutation studies using a series of truncated PKC mu- 
tants [15] or a site-directed mutant [16] have shown that 
alterations to the auto-inhibitory region lead to activity. 
In order to further define the role of the auto- inhibitory 
region of PKC, we generated mutant PKC with site- 
directed mutations in this region. In this study, basic 
residues found in the auto-inhibitory egion were panic- 
ulary targeted for mutations, since basic residues in the 
analogus positions are usually the critical determinants 
for PKC substrates [17,18]. 
2. MATERIALS AND METHODS 
2.1. Construction fmutant PKC eDNA expression vectors 
Three different mutant PKC~ cDNAs were constructed using bo- 
vine PKCg eDNA [19] and the following eight synthetic oligonucleo- 
tides: 
CPMI. 5"-CGCCGCAGGCGTCGCCAACCGCTTCGCCCGCA- 
AAGGGGCG-3' 
CPM2o 5'.CAGCGCCCCTTTGCGGGEGAAGCGG'I'FGGCGA- 
CGTCCTGCGG-Y 
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CPM3, 5'-CTGAGGCAGAAGAACGTGCACGAGGTGAAGA- 
ACCACCGCTTCATCG-3 '  
CPM4, 5'-CGCGCGATOAAGCGGTGGTTC'~CACCTCGTG- 
CACGTTCTTCTGCCT-3' 
CPMS, 5'-CGCCGCAGGACGTCGCCAACCGCTTCGCCGCT- 
GCTGGGGCG-3' 
CPM6, 5'-CAGCGCCCCAGCAGCGGCGAAG CGGTTGGCG- 
ACGTCCTGCGG-3' 
CPMT, 5'-CTGGCTCAGAAGAACGTGCACGAGGTGAAGA- 
ACCACCGCTTCATCG-3' 
CPMg, 5'-CGCGCGATGAAGCGGTGGTTCTTCACCTCGTG. 
CACGTTCTTCTGAGC.3' 
CPMI and CPM2, CPM3 and CPM4, CPM5 and CPM6° CPM7 
and CPM3 were annealed after phosphorylation to make the doable- 
stranded DNA fragments, CPMA, CPMB, CPMC and CPMD, re. 
spectively. CPMA and CPMD, CPMB and CPMC, and CPMC and 
CPMD were ligated into the Narl-BssHIll site of pSRg-PKCa [6,20] 
to produce, pSR¢.PKC A'":~, pSR~.PKC ^~"'-'.='3 and pSRa. 
PKC ^ ~"'~:':~''~, respectively (Table I, columns 1and 2). One base pair 
ch:mge generating an AatlI site without affecting the amino acid 
sequence was introduced into the oligonucleotides to aid in the screen. 
ing procedure. The inserted oligonaeleotide portions were verified by 
sequencing using Sequenase (US Biochem. Corp.). 
2.2. hnmunoblotting attalysis and [SH]phorbo[ 12.13-dibuo,late 
(PDBu) binding actl~,ity of the mutant PKCs 
lmmunoblotting analysis was performed as described [15] using 
PKC the monoclonal ntibody, MC-$ (Amersham). Soluble and par- 
ticulate fractions were prepared by the following procedure. COS7 
cells (! × 10 ~) were transfeeted by the DEAE-dextran method [20] with 
5/ag of pSR= vector, pSR~-PKC, pSRa.PKC a'~-'',='a, pSR¢.PKC Aj~'~, 
or pSR0~.PKC a{='-~'~aT. Cells were harvested 48 h after transfection, 
suspended in 100/~1 of buffer A (20 mM Tris.HCl, pH 7.5, 10 mM 
EDTA, 2 mM EGTA, 0.25 M sucrose, 2mM 2-mercaptoethanol, and 
100/~M phenylmethylsulfonyl fluoride), and sonicated for 20 s. Cell 
homogenates were centrifuged at l0 s x g for 1 h and the supernatants 
were used as soluble fractions. The pellets were solubilized in 100/Jl 
of buffer A containing i% SDS and the supernatants, following cen- 
trifugatioa under the same conditions tated above, were used as 
particulate fractions. [~H]PDBu binding was performed as described 
previously [6], 
2.3. In vitro kinase activity of the mutant PKCs 
In vitro kinase assays were performed as previously described [15] 
with the following modifications. Briefly, COS7 cells (1×10°/10 cm 
plate × 3) transfeeted with mutant PKC plasmids were harvested and 
. homogenized in 0.45 ml of i~-cold buffer A containing 0,5% Triton 
X-100 and sonicated for 20 s. Cell homogenates were centrifuged at 
10 s × g for 1 h. The supernatants were adsorbed on DEAE-Sephacel 
columns (0.5 ml) and eluted stepwise with butter A containing 90 mM 
and 200 mM NaCl. Protein kinase activity was measured using histone 
HI as substrates. The reaction mixture (100 pl) contained 20 mM 
Tris-HCI, pH 7.5, 5 mM MgCI,, 0.25 mM CaCl~, 0.1 mM EDTA, 0.1 
mM EGTA, 10/tM [T-~-~P]ATP (1,000-3,000 cpm/pmol), 4/ag/ml 
phosphatidyl~gring, homogenate, and 10 ,uM histon¢ H! or 100 mM 
EGF-R peptide. After incubation for 10 rain at 30°C, a 40/al aliquot 
was removed from the reaction mixture and applied to P-81 paper 
(Whatman); free [~':'-P]ATP was removed by washing with 75 mM 
H~POa 
2.4. The level of phosphoryfation of the mutant PKCs in rive 
lmmunoprecipitation of PKC was performed in the following man- 
ner. Transiently transfected COS7 cells (1×106) were labeled with I 
mCi of ['~-'P]orthophosphate (Amersham) or Tran.['~S] (ICN) for 12 
h. Cell homogenates were prepared in 100/~1 ofbuffer A supplemented 
with 1% SDS and centrifuged at 10 ~ x g. 100/tl of buffer B (40 mM 
Tris-HCl, pH 7.5, 10 mM EDTA, 2% Triton X-100, 2% sodium de- 
oxycholate, 5 mg/ml bovine serum albumin, 2 mM Na.,MoO~, 100/tM 
phenylmethylsulfonyl fluoride) and 5 ItS of MC-5 monoclonal nti- 
body were added tc 50/~l of.~¢b cell ,honao~enate nd gently shaken 
at 4°C for 6 h. lmmunoeomplex was removed by adding protein 
G-agarose and washing several times with buffer B without BSA. 
Finally, the pellets were dissolved in 15 ltl of Laemmli sample buffer, 
boiled and electrophoresed ona 7.5% SDS-polyacrylamid¢ gel. 
2.5. Bioassays for PKC acth,ity h~ cells 
Transfeetions for Jurkat cells and lueiferase assays were performed 
as previously described [20]. The c-Jbs-luciferase plasmid carries 0.4 
kb of the 5' flanking region of the c.fos gone 121]. Injection of mutant 
PKC plasmids and the assay for germinal vesicle breakdown (GVBD) 
in Xenopus laev/s oocytes were performed as described [6]. Briefly, a 
total of 0.01-10 ng of PKC plasmid DNA in 10 nl of distilled water 
was injected into the nucleus of each oocyte. 7-10 oocytes were used 
per sample and observation was made between 12 and 18 b after 
injection. Initiation of the GVBD was judged by the appearance era 
white spot at the animal pole, and the frequency was calculated. 
pSRa-PKAC [6], which lacks the coding region for the regulatory 
domain and thus is constitutively active, was used as a positive control 
for tlte~e biological assays, 
3. RESULTS 
3.1. Expression of mutant PKCs in COSY cells and phor- 
bol ester binding 
The biochemical properties of the mutant PKCs were 
assessed in a COS7 cell over-expression system, as de- 
scribed in Materials and Methods. Transfection with 
either wild-type or mutant PKC eDNA plasmids 
yielded a 6-9-fold increase in immunoreactive PKC 
over the endogenous level (Table I, column 3). Prote- 
olytic products were not detected for either the wild- 
type or the mutant PKCs (see Fig. 1). In examining 
phorbol ester binding of the mutant PKCs, approxi- 
mately a 10-fold increase in [3H]PDBu binding was de- 
tected in COS7 cells expressing the wild-type or the 
mutant PKC (Table 1, column 4). Therefore, the muta- 
tions in the pseudo-sttbstrate region did not impair the 
phorboi ester binding activity. 
3.2. Subcelhdar localization of mutant PKCs 
The subcellular localization of wild-type and mutant 
PKCs was investigated (Fig. 1). While endogenous PKC 
was found primarily in the soluble fraction which is 
extracted from the cytosol by divalent cation chelators, 
wild-type PKC expressed from transfeeted eDNA was 
distributed in both the soluble and paniculate fractions. 
This indicates that half of the wild-type PKC product 
in this expression system is trapped in the particulate 
fraction. PKC A~'2z'~3 and PKC Ala27 were also found in 
both the soluble and particulate fractions, in a similar 
ratio as that observed for wild-type PKC. In contrast, 
PKC At='22'~'3'27 was found primarily in the particulate 
fraction with only a small amount in the soluble frac- 
tion. This suggests that PKC Ala22'2'~'27 is more tightly 
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Fig. I. Subcellular localization of wild-type and mutant PKCs. Wild- 
type and mutant PKCs in the soluble (panel A) and the particulate 
(panel B) fractions from COS7 cells were detected by immunoblotting 
analysis. Samples were prepared from cells transfected with pSRa 
vector (lane 1 ), pSRg- PKC (lane 2), pSR,'r-PKC ^]~::'~3 (lane 3), pSRot- 
PKC AI:7 (lane 4), and pSR~-PKC ^1~''':'~''~7 (lane 5). 
associated with the particulate fraction than wild-type 
PKC,  PKC At':'~'~'a or PKC at:'7. In an immunocytochem- 
ical study using indirect immunofluoresence, wild-type 
PKC, PKC A1~2-''23 and PKC At:'7 showed a diffuse ey- 
tosolic staining (data not shown). Only PKC Aia22'23'27 
was hardly detected in the cytosol by the same method, 
suggesting that it may have a different localization in 
the cell or that the epitope of this mutant is masked. 
Table I1 
In vitro activity of mutant PKCs expressed in COS7 cells 
Transfected 99 mM eluate (xl0 ~ cpm ~) 200 mM eluat¢ (xl03 cpm') 
mutant 
PKC eDNA EGTA PS÷Ca÷TPA EGTA PS+Ca+TPA 
pcDSR,t 2.5 12.5 4.3 9.5 
vcstor 
PKC (wild 3.5 49.2 7.7 9.1 
type) 
PKC AI~::':'~ 9.1 15.6 105.1 146.0 
PKC Al~'7 15.2 26.2 122.9 182.8 
~-'P incorporated in histone Hi as described in Materials and 
Method~ 
slight increase in kinase activity was also observed in the 
90 mM fraction, suggesting that additional PKC '~-~2,-'3 
and PKC '~ta27 elated in this fraction. PKC a'ta~.~-~'27 was 
much more refractory to solubilization, as described in 
the former section, and very little amount of  soluble 
PKC Ala2''23.27 could be obtained. Therefore its kinase 
activity could not be directly compared with the wild- 
type or other mutant PKCs. Since expression of 
PKC/~2-''2'~'27 did not confer an increase in kinase ae- 
tivcity on the particulate fraction (data not shown), it 
is unlikel~ that PKC A~"-~-''-'3:-7 has a high level of kinase 
aetivtiy. 
3.3. In vitro kinase assay of the part&fly purified mutant 
PKCs 
Wild-type and mutant PKCs expressed in COS7 cells 
were partially purified and kinase activity was deter- 
mined as described in Materials and Methods (Table 
II). Wild-type PKC expressed in COS7 cells was col- 
lected in the 90 mM NaCI fraction and gave a 4-fold 
increase in activator-dependent kinas¢ activity com- 
pared to endogenous PKC. PKC Al°-~z-~3 and PKC At~'7 
primarily eluted in the 200 mM NaCl elution, rendering 
a high level of activator-independent ki ase activity in 
this fraction. Its kinase activity was only slightly in- 
creased (1.5-fold) by the addition of the activators. A 
3.4. The level of phosphorylation of the mutant PKCs in 
COS7 cells 
COS7 cells transfected with wild-type or mutant PKC 
plasmids were labeled with [35S]methionine or [3-'P]or- 
thophosphate for 12 h and immunoprecipitation was 
performed using the monoclonal antibody, MC-5 (Fig. 
2A and B). Wild-type and mutant PKCs expressed in 
COS7 cells were detected as two bands of 74 kDa and 
77 kDa, in approximately the same amount (Fig. 2A). 
While phosphorylation f endogenous PKC could not 
be detected (Fig. 2B, lane 1), a low level of phosphoryl- 
ation was detected for the wild-type PKC expressed in 
the cell (Fig. 2B, lane 2). The phosphorylated PKC band 
Table I 
PKC mutants in the auto.inhibitory egion and their expression and PDBa binding in COS7 cells 
Transfected Coding sequence of ':Sl count of the [~H]PDBu binding 
mutant PKC cDNA the auto-inhibitory immanoblot band per 10" ceils 
region x l0 t cpm xl0 -~ clam 
(relative amount) (relative amount) 
peDSR~veetor 6.08( 1.0) 
PKC (wild-type) Arg~"~-Lys-Gly-Ala-Leu-Arg 34.5 (5.7) 
PKC At''':':~ Ala-Ala-Gly-Ala-Leu-Arg 157.2 (9.4) 
PKC A~'7 Arg-Lys-Gly-Ala-Leu-Ala 148.9 (8.0) 
PKC ^ 1"-'-'''-3':7 Ala-Ala-Oly-Ala-Leu-Ala 148.3 (7.9) 
11.2 (1.0) 
90.9(8.1) 
! 50,9 (13.5) 
140.4 (12.5) 
113.3 (I0.1) 
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FiB, 2. Phosphorylation f wild-type and mutant PKCa in rive. lm- 
munoprecipitation was performed on extracts from cell~ labell~ with 
['~SSlmethionine (panel A) or [~:P]orthophosphate (panel B) from cells 
translated with pSR~ vector (lane l), pSR~-PKC (lane 2), pSR~- 
PKC ^ t~-~-~'-~ (lane 3), pSR~-PKC ~t~:7 (lane 4) and pSR~t-PKC ^~-':'-''~'~7 
(lane 5). Lane M, molecular weil~ht markers. 
corresponded to the upper 77 kDa band. Phosphoryla- 
tion levels were significantly higher for PKC A*"22''3 and 
PKC at''-~7 than for the wild-type PKC. In contrast, 
PKC A1":'''~3'27 had a lower phosphorylation level similar 
to that of the wild-type PKC. 
3.5. Activation of c-los protnoter and hlitiation of G VBD 
by the mutant PKC plasmids 
The biological activity of  the mutant PKCs was ex- 
amined in two independent assays which have been de- 
scribed previously [6]. The mutant PKC eDNA plas- 
mids were transfected into Jurkat cells with a c-fos- 
luciferase reporter gene (Fig. 3A). The c-fos-luciferase 
gene had a low basal expression level in Jurkat cells and 
was not activated by co-transfection with pSR~z-PKC, 
demonstrating that wild-type PKC is inactive by itself. 
Co-transfection with pSR~-PKC AL~22'-~3 and pSRcz- 
PKC At"27 did not activate the c-fos-luciferase gene ei- 
ther. In contrast, transfection with pSR0~-PKC a~''-''-'23'27 
significantly enhanced expression of the e.fos-luciferase 
gene. The level of enhancement was comparable to that 
of pSRot-PKAC, which lacks the whole regulatory do- 
main and thus is constitutively active [6]. 
The biological activity of the mutant kinases were 
characterized by another assay employing Xenopus lae- 
vis oocytes which induce germinal vesicle breakdown 
(GYBD) after the addition of phorbol esters [22]. This 
oocyte system provides a sensitive bioassay to detect 
constitutively active PKC, in vivo [6]. None of the 
oocytes injected with pSR~-PKC plasmid induced 
GVBD, indicating that wild-type PKC is inactive in 
oocytes (Fig. 3B). In contrast, 80% of the ooeytes in- 
jected with the positive control, pSR~z-PKAC, initiated 
GVBD in the absence of phorbol ester. Among the 
mutant PKC plasmids, irJjectlo~ of pSRa-PKC Aia22.2"a'27 
gave the highest initiation rate of GVBD, comparable 
to that observed with pSRa-PKAC. Injection of pSRcz- 
PKC A1"22'~-3 or pSRa-PKC At"27 also initiated GVBD but 
~o0 
/ F / --.e- PKeA,~7 
!i 
o o :~ 1 'o 1 '5 
DNA 0Jg) 
100 s :/If\ 
o--;AcC! 
10 1 0.1 0.01 
DNA (ng) 
Fig. 3. Biological activity of mutant PKCs, (A) Activation era e.fos- 
lueirerase gene in Jurkat cells by expressing mutant PKCs, (B) Initia- 
tion or GVBD in Xenopus laei,ia oocytes by expressing mutant PKCs. 
at a lower frequency. Injection of higher concentrations 
of mutant PKC plasmids appeared to interfere with the 
GVBD process. 
4. DISCUSSION 
By introducing 'changed-to-alanine' mutations into 
the basic residues in the auto-ihibitory region of PKC, 
mutants with different biological and biochemical prop- 
erties were generated. PKC A~"'~2'2~ and PKC Alu27 had a 
high level of activator-independent in vitro kinase activ- 
ity, indicating that substitution of one or two basic res- 
idues are sufficient to distroy the pseudo-substrate inhi- 
bition. The tight dependence of this inhibition to these 
basic residues uggests that this region might be inter- 
acting with the catalytic enter by a mechanism similar 
to the actual substrate. These mutants with high cata- 
lytic activity localized in both cytosolic and particulate 
fractions, indicating that particulate association does 
not correlate with in vitro kinase activity or in rive 
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phosphorylation. The other mutant, PKC Am''~'-~':7, was 
tightly associated with the particulate fraction. After 
phorbol ester treatment of COS7 cells, endogenous 
PKC was not found in the cytosolic fraction but was 
only detected in the particulate fraction, indicating that 
PKC underwent ranslocation (data not shown). Like- 
wise, the association of PKC ala22.23.27 with the particu- 
late fraction might reflect a similar translocational event 
that occurs following phorbol ester treatment. It is un- 
likely, although it cannot be ruled out, that the increase 
in the hydrophobie residues in the auto-inhibitory re- 
gion accounts for the particulate association, since the 
hydropathic profile of PKC A~"2-~,23 and PKC Ata22.'-3'27 did 
not show a significant difference. Whatever is the cause 
of the difference in the localization, the proper structure 
of the auto-inhibitory region is needed for the cytosolic 
retention of  PKC. 
High levels of kinase activity per se, as demonstrated 
in PKC At"22:-~ and PKC A~":7, was insufficient o elicit full 
biological activity after expression. Instead, 
PKC A1~''::'3':7, which was most tightly associated with 
the particulate fraction, was much more biologically 
potent. Although in vitro kinase activity of PKC A1"22'23'27 
could not be rigorously demonstrated, we assume that 
it had enough kinase activity to elicit biological re- 
sponses, and, by translocating to the particulate frac- 
tion, it facilitated the response by tightly coupling with 
the target proteins, On the other hand, the lower biolog- 
ical potentials of PKC Al"':,~-~ and PKC Ah27 can be ex- 
plained by their inefficiency of access to the target pro- 
teins. On the other hand, it may also be possible that 
elearlance of active PKC from the cytosol may be re- 
quired to elicit a biological response [23]. These mutant 
PKCs with different biological and biochemical proper- 
ties may be useful tools to investigate the signal 
transduction events involving PKC in the cell. 
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